The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells
about
DNA methylation-associated inactivation of TGFbeta-related genes DRM/Gremlin, RUNX3, and HPP1 in human cancersGlobal gene expression analysis in time series following N-acetyl L-cysteine induced epithelial differentiation of human normal and cancer cells in vitroDMH1, a small molecule inhibitor of BMP type i receptors, suppresses growth and invasion of lung cancerAggressive melanoma cells escape from BMP7-mediated autocrine growth inhibition through coordinated Noggin upregulation.Silencing BMP-2 expression inhibits A549 and H460 cell proliferation and migrationEffect of grafting BMP2-derived peptide to nanoparticles on osteogenic and vasculogenic expression of stromal cellsA dose- and time-controllable syngeneic animal model of breast cancer microcalcificationExpression of bone morphogenetic protein-2 and its receptors in epithelial ovarian cancer and their influence on the prognosis of ovarian cancer patientsThe Yin and Yang of bone morphogenetic proteins in cancer.Gremlin is overexpressed in lung adenocarcinoma and increases cell growth and proliferation in normal lung cells.Independent and cooperative roles of tumor necrosis factor-alpha, nuclear factor-kappaB, and bone morphogenetic protein-2 in regulation of metastasis and osteomimicry of prostate cancer cells and differentiation and mineralization of MC3T3-E1 osteobSignaling mechanisms of the epithelial-mesenchymal transition.BMP-2 promotes oral squamous carcinoma cell invasion by inducing CCL5 release.Treatment effects of rhBMP-2 on invasiveness of oral carcinoma cell lines.BMP2 response pattern in human lung fibroblasts predicts outcome in lung adenocarcinomasModulation of Bone Morphogenetic Protein (BMP) 2 gene expression by Sp1 transcription factors.Inhibition of BMP and of TGFβ receptors downregulates expression of XIAP and TAK1 leading to lung cancer cell death.The Value of SPECT/CT in Monitoring Prefabricated Tissue-Engineered Bone and Orthotopic rhBMP-2 Implants for Mandibular ReconstructionBone morphogenetic protein modulator BMPER is highly expressed in malignant tumors and controls invasive cell behavior.Application of bone morphogenetic proteins in orthopaedic practice: their efficacy and side effects.Induction of Smad1 by MT1-MMP contributes to tumor growth.GalNAc-T14 promotes metastasis through Wnt dependent HOXB9 expression in lung adenocarcinomaSafety and efficacy of use of demineralised bone matrix in orthopaedic and trauma surgery.SMAD Signaling in the Airways of Healthy Rhesus Macaques versus Rhesus Macaques with Asthma Highlights a Relationship Between Inflammation and Bone Morphogenetic Proteins.Chordin-Like 1 Suppresses Bone Morphogenetic Protein 4-Induced Breast Cancer Cell Migration and InvasionInfluence of simultaneous targeting of the bone morphogenetic protein pathway and RANK/RANKL axis in osteolytic prostate cancer lesion in bone.Species-specific cis-regulatory elements in the 3'-untranslated region direct alternative polyadenylation of bone morphogenetic protein 2 mRNA.Bone formation induced by BMP-2 in human osteosarcoma cells.Bone morphogenetic proteins and cancer: review of the literature.Neoplasia following use of BMPs: is there an increased risk?A Review of the Clinical Side Effects of Bone Morphogenetic Protein-2.Bone morphogenetic protein signaling in musculoskeletal cancer.The protein kinase LKB1 negatively regulates bone morphogenetic protein receptor signalingEmerging roles of the bone morphogenetic protein pathway in cancer: potential therapeutic target for kinase inhibition.Bone morphogenetic protein 2 mediates epithelial-mesenchymal transition via AKT and ERK signaling pathways in gastric cancer.BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation.Proprotein convertase 5/6a is associated with bone morphogenetic protein-2-induced squamous cell differentiation.Bone morphogenetic protein-focused strategies to induce cytotoxicity in lung cancer cellsSmall molecule antagonist of the bone morphogenetic protein type I receptors suppresses growth and expression of Id1 and Id3 in lung cancer cells expressing Oct4 or nestinBone morphogenetic protein type I receptor antagonists decrease growth and induce cell death of lung cancer cell lines.
P2860
Q24650975-237FF029-5AE2-4B2C-B768-0E58DE3B99A0Q24816361-24F8AD13-C1C5-4315-A662-EED211072216Q28511586-056CD01F-9EE8-4A42-AA6F-A7EB3F9CD018Q30487367-2B5F9677-D276-4A7A-9C5B-45D87E49452FQ33804283-E3338770-35D2-44A7-89E4-F79ADBA5DE4AQ33827070-B7FD9D75-7B9C-4259-8516-BED46A2DB550Q33905755-BF8715D7-36CD-4F4E-81E7-80DD56C64254Q34008631-68973E7A-0767-4A54-B400-683FE41C4777Q34127207-BD7F6AE9-4F59-4FD4-919A-F43E898E1C5BQ34369398-1E0815B9-6960-441C-B205-AA07BBC6911CQ34971654-78D45F3A-98EF-446F-B73A-FBB97FB03BFBQ35213019-96ACB266-F493-40FA-A8F5-9C1260BF7ABCQ35290842-924B9FFC-B442-4222-A8BF-84180DA16015Q35491924-D4E9E869-3C77-4036-A02B-F9F3413E8959Q35575590-18E9C768-38F7-4994-AB5C-20F7514B63C5Q35915965-2B9A45EB-BC65-4146-904B-D66A0AFA2FC5Q35980393-DB7CC7E5-46FF-45AA-A233-9153E4BD60CFQ36028835-57C9421E-DE6D-4826-AC1A-66D89AA75126Q36035290-9B4D3605-4650-4637-8CDA-6E203A628FB8Q36040760-9B085CA1-348C-49C5-AFD2-8A761AA76E8BQ36157381-49BDC2BD-E0FB-4E5F-B0D8-4A35FBE50548Q36561625-12903880-0922-47D8-BF1B-36FA9C390517Q36624999-CACC712E-1CA5-4AAC-A748-C313556A8A07Q36765992-B6D390BB-1C12-4C9A-BE68-00F52AC474E6Q36878808-96A5074A-71A0-4DEB-BE50-99968977BADAQ37131738-97F0433C-823F-45CF-A687-128D6E37E8BBQ37141487-79CCB2D4-76E2-4CC7-8CDC-11EA2779D339Q37313318-9055A83B-8247-4965-804B-58F2EBA6807DQ37665275-C668E64A-6040-4AD2-8A7F-2AF6BF893781Q38256860-3C3325DA-B519-4DE9-9D8D-D7F499FB48CDQ38726586-55751143-4F7C-4075-8EF8-36855F7B65ACQ38797636-B9250084-A250-4816-B763-23DF79F63940Q38809268-EDBADC9C-8B8D-4AAB-B2AB-C197B7844247Q38928611-D0CDE40E-E638-4EA4-AD43-9F4D774C0294Q38935109-DF507290-2AB3-49D0-BE34-32AE688B0343Q38937195-3EBC9077-5EF2-4538-9D88-B332C8E94A09Q38944529-99C09A9E-41F3-4F16-815E-F0849A6AE318Q38997362-FC7CD788-6B22-44B0-9EB2-1CEE10965E88Q39070550-5A97DC47-EDA6-4BED-AC40-62C828FEF01FQ39164711-95B46D37-F238-4A8D-986C-18A3AB39E5D5
P2860
The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The mature bone morphogenetic ...... tes tumor growth of A549 cells
@ast
The mature bone morphogenetic ...... tes tumor growth of A549 cells
@en
The mature bone morphogenetic ...... tes tumor growth of A549 cells
@en-gb
The mature bone morphogenetic ...... tes tumor growth of A549 cells
@nl
type
label
The mature bone morphogenetic ...... tes tumor growth of A549 cells
@ast
The mature bone morphogenetic ...... tes tumor growth of A549 cells
@en
The mature bone morphogenetic ...... tes tumor growth of A549 cells
@en-gb
The mature bone morphogenetic ...... tes tumor growth of A549 cells
@nl
prefLabel
The mature bone morphogenetic ...... tes tumor growth of A549 cells
@ast
The mature bone morphogenetic ...... tes tumor growth of A549 cells
@en
The mature bone morphogenetic ...... tes tumor growth of A549 cells
@en-gb
The mature bone morphogenetic ...... tes tumor growth of A549 cells
@nl
P2093
P3181
P356
P1433
P1476
The mature bone morphogenetic ...... tes tumor growth of A549 cells
@en
P2093
Elaine M Langenfeld
Fadi Abou-Nukta
John Langenfeld
Peter Amenta
Stephen F Lowry
Steve E Calvano
P304
P3181
P356
10.1093/CARCIN/BGG100
P407
P577
2003-09-01T00:00:00Z